SNIPERs have worked well not only in cancer targets (e.g., targeting estrogen receptor α (ERα), bromodomain-containing protein 4 (BRD4)) but also in immune diseases and neurodegenerative disease targets, such as mutant tau and Htt [37,39,40]. The gene discussed is MAPT; the disease is neurodegenerative disease.